Eosinophils in the pathogenesis of paediatric severe asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 2, 2014, Pages 143-148

  Saglani, Sejal ^a,b   Lloyd, Clare M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

eosinophils; innate lymphoid cells; interleukin 5; remodelling; severe asthma

Indexed keywords

BENRALIZUMAB; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 5; MEPOLIZUMAB; SMAD3 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1;

ADAPTIVE IMMUNITY; AIRWAY REMODELING; ALTERNARIA ALTERNATA; ASTHMA; BRONCHUS BIOPSY; CHILDHOOD DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EOSINOPHIL COUNT; EOSINOPHILIA; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; INNATE LYMPHOID CELL; LEUKOCYTE COUNT; LOEFFLER PNEUMONIA; LUNG PARENCHYMA; LYMPHOID CELL; METABOLIC SYNDROME X; NEUTROPHIL; OBESITY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPUTUM ANALYSIS; TH2 CELL; TISSUE SPECIFICITY;

ANIMALS; ASTHMA; CHILD; DRUG RESISTANCE; EOSINOPHILS; HUMANS; IMMUNITY, INNATE; TH17 CELLS; TH2 CELLS;

EID: 84896731495     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000045     Document Type: Review

References (33)

1. Bossley CJ, Fleming L, Gupta A, et al. Pediatric severe asthma is character-ized by eosinophilia and remodeling without T(H]2 cytokines. J Allergy Clin Immunol 2012; 129:974-982.
2. Ullmann N, Bossley CJ, Fleming L, et al. Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma. Allergy 2013; 68:402-406.
3. Hastie AT, Moore WC, Li H, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 2013; 132:72-80.
4. Fleming L, Wilson N, Regamey N, Bush A. Use of sputum eosinophil counts to guidemanagement inchildren with severe asthma. Thorax 2012;67:193-198.
5. Fleming L, Tsartsali L, Wilson N, et al. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax 2012; 67:675-681.
6. Persson C. Lysis of primed eosinophils in severe asthma. J Allergy Clin Immunol 2013; 132:1459-1460.
7. Kano G, Almanan M, Bochner BS, Zimmermann N. Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation. J Allergy Clin Immunol 2013; 132: 437-445.
8. Muniz-Junqueira MI, Barbosa-Marques SM, Junqueira LF Jr. Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children. Allergy 2013; 68:911-920.
9. Volbeda F, Broekema M, Lodewijk ME, et al. Clinical control of asthma associates with measures of airway inflammation. Thorax 2013; 68:19-24.
10. Nair P, Ochkur SI, Protheroe C, et al. Eosinophil peroxidase in sputum repre-& sents a unique biomarker of airway eosinophilia. Allergy 2013; 68:1177-1184. A potential novel marker of eosinophil activity in induced sputum that may be useful in determining airway eosinophilia, and prevent the need for sputum cell counts.
11. Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic & asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012; 380:651-659.
12. Hashimoto S, Bel EH. Targeting IL-5 in severe asthma: a DREAM come true? Lancet 2012; 380:626-627.
13. Laviolette M, Gossage DL, Gauvreau G, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol 2013; 132:1086-1096.
14. Assa'ad AH, Rothenberg ME. Eosinophilic asthma: insights into the effects of reducing IL-5 receptor-positive cell levels. J Allergy Clin Immunol 2013; 132: 1097-1098.
15. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells: a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13:145-149.
16. Barlow JL, Bellosi A, Hardman CS, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreac-tivity. J Allergy Clin Immunol 2012; 129:191-198.
17. Barlow JL, Peel S, Fox J, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013; 132:933-941.
18. Saglani S, Lui S, Ullmann N, et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol 2013; 132:676-685.
19. Bernink JH, Peters CP, Munneke M, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013; 14:221-229.
20. Mjosberg J, Bernink J, Golebski K, et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012; 37:649-659.
21. Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25-and IL-33-responsive type2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12:1055-1062.
22. Barnig C, Cernadas M, Dutile S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 2013; 5:174ra26.
23. Nussbaum JC, Van Dyken SJ, von MJ, et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013; 502:245-248.
24. Lloyd CM, Saglani S. Eosinophils in the spotlight: finding the link between obesity and asthma. Nat Med 2013; 19:976-977.
25. Molofsky AB, Nussbaum JC, Liang HE, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013; 210:535-549.
26. Calixto MC, Lintomen L, Andre DM, et al. Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS One 2013; 8:e76786.
27. Desai D, Newby C, Symon FA, et al. Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma. Am J Respir Crit Care Med 2013; 188:657-663.
28. Jensen ME, Gibson PG, Collins CE, Wood LG. Airway and systemic inflammation in obese children with asthma. Eur Respir J 2013; 42: 1012-1019.
29. Grotta MB, Squebola-Cola DM, Toro AA, et al. Obesity increases eosinophil activity in asthmatic children and adolescents. BMC Pulm Med 2013; 13:39.
30. Fattouh R, Al-Garawi A, Fattouh M, et al. Eosinophils are dispensable for allergic remodeling and immunity in a model of house dust mite-induced airway disease. Am J Respir Crit Care Med 2011; 183:179-188.
31. Yasukawa A, Hosoki K, Toda M, et al. Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells. PLoS One 2013; 8: e64281.
32. Miyata J, Fukunaga K, Iwamoto R, et al. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J Allergy Clin Immunol 2013; 131:353-360.
33. Ha SG, Ge XN, Bahaie NS, et al. ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48. Nat Commun 2013; 4:2479.